サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1317766

更年期障害市場：治療、製品タイプ、適応症、流通別-2023～2030年の世界予測

Menopause Market by Treatment, Product Type, Indication, Distribution Challenge - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 199 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
更年期障害市場：治療、製品タイプ、適応症、流通別-2023～2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 199 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

更年期障害の世界市場は、2023年に177億9,000万米ドル、CAGR 6.83%で大幅な成長が予測され、2030年には282億9,000万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の更年期障害市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.更年期障害の世界市場規模および予測は？

2.予測期間中、世界の更年期障害市場を形成するCOVID-19の阻害要因と影響は？

3.更年期障害の世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は？

4.更年期障害の世界市場における競争戦略は？

5.更年期障害の世界市場における技術動向と規制の枠組みは？

6.更年期障害の世界市場における主要ベンダーの市場シェアは？

7.更年期障害の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 血管運動神経症状およびその他の更年期障害の有病率が高い
      • 更年期障害の健康に対する意識の高まり
      • 治療のための新薬承認数の増加
    • 抑制要因
      • ホルモン剤に関連する副作用とジェネリック医薬品の入手可能性
    • 機会
      • 更年期障害に対するハーブ療法の普及率
      • 栄養補助食品の利点を裏付ける研究の増加
    • 課題
      • 発展途上国には高度なヘルスケアインフラが不足している
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 更年期障害市場：治療別

  • イントロダクション
  • 栄養補助食品
  • OTC医薬品
    • ホルモン製品
      • エストロゲンと他の薬の併用
      • エストロゲンとプロゲスチンの配合剤
      • エストロゲンのみの薬
      • プロゲスチンのみの薬
    • 非ホルモン製品

第7章 更年期障害市場：製品タイプ別

  • イントロダクション
  • ゲル
  • 注射
  • 経口
  • パッチ
  • ピル
  • 粉末
  • スキンクリーム
  • スキンスプレー（経皮吸収）
  • 膣クリーム
  • 膣リング

第8章 更年期障害市場：適応症別

  • イントロダクション
  • ドライアイ
  • 乾燥肌
  • ほてり
  • 気分の変動、軽度のうつ病、過敏症
  • 寝汗と冷えのぼせ
  • 骨粗鬆症
  • 不眠
  • 尿意切迫感
  • 膣の乾燥

第9章 更年期障害市場：流通別

  • イントロダクション
  • 病院薬局
  • オンラインストア
  • 小売薬局

第10章 南北アメリカの更年期障害市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の更年期障害市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの更年期障害市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第14章 掲載企業一覧

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. MENOPAUSE MARKET RESEARCH PROCESS
  • FIGURE 2. MENOPAUSE MARKET SIZE, 2022 VS 2030
  • FIGURE 3. MENOPAUSE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. MENOPAUSE MARKET SIZE, BY TREATMENT, 2022 VS 2030 (%)
  • FIGURE 5. MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
  • FIGURE 6. MENOPAUSE MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
  • FIGURE 7. MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2022 VS 2030 (%)
  • FIGURE 8. MENOPAUSE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. MENOPAUSE MARKET DYNAMICS
  • FIGURE 10. MENOPAUSE MARKET SIZE, BY TREATMENT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. MENOPAUSE MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. MENOPAUSE MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. MENOPAUSE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. MENOPAUSE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. MENOPAUSE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 5. MENOPAUSE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 7. MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 9. MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. MENOPAUSE MARKET SIZE, BY COMBINATION ESTROGEN AND OTHER MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. MENOPAUSE MARKET SIZE, BY COMBINATION ESTROGEN AND PROGESTIN MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. MENOPAUSE MARKET SIZE, BY ESTROGEN-ONLY MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. MENOPAUSE MARKET SIZE, BY PROGESTIN-ONLY MEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. MENOPAUSE MARKET SIZE, BY NON-HORMONAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. MENOPAUSE MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. MENOPAUSE MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. MENOPAUSE MARKET SIZE, BY ORAL DOSAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. MENOPAUSE MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. MENOPAUSE MARKET SIZE, BY PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. MENOPAUSE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. MENOPAUSE MARKET SIZE, BY SKIN CREAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. MENOPAUSE MARKET SIZE, BY SKIN SPRAY (TRANSDERMAL), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. MENOPAUSE MARKET SIZE, BY VAGINAL CREAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. MENOPAUSE MARKET SIZE, BY VAGINAL RING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 27. MENOPAUSE MARKET SIZE, BY DRY EYES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. MENOPAUSE MARKET SIZE, BY DRY SKIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. MENOPAUSE MARKET SIZE, BY HOT FLASHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. MENOPAUSE MARKET SIZE, BY MOOD SWINGS, MILD DEPRESSION & IRRITABILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. MENOPAUSE MARKET SIZE, BY NIGHT SWEATS AND COLD FLASHES., BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. MENOPAUSE MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. MENOPAUSE MARKET SIZE, BY TROUBLE SLEEPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. MENOPAUSE MARKET SIZE, BY URINARY URGENCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. MENOPAUSE MARKET SIZE, BY VAGINAL DRYNESS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 37. MENOPAUSE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. MENOPAUSE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. MENOPAUSE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 124. PHILIPPINES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 130. SINGAPORE MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SINGAPORE MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SINGAPORE MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH KOREA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SOUTH KOREA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 142. TAIWAN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. TAIWAN MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. TAIWAN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 148. THAILAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. THAILAND MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 150. THAILAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 154. VIETNAM MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. VIETNAM MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. VIETNAM MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 167. DENMARK MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. DENMARK MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. DENMARK MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 172. EGYPT MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 173. EGYPT MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. EGYPT MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 175. EGYPT MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 178. FINLAND MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 179. FINLAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. FINLAND MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 181. FINLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 184. FRANCE MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 185. FRANCE MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. FRANCE MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 187. FRANCE MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 190. GERMANY MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 191. GERMANY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. GERMANY MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 193. GERMANY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 196. ISRAEL MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 197. ISRAEL MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. ISRAEL MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. ISRAEL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 202. ITALY MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 203. ITALY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. ITALY MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 205. ITALY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 208. NETHERLANDS MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. NETHERLANDS MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 214. NIGERIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 215. NIGERIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. NIGERIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 217. NIGERIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 220. NORWAY MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 221. NORWAY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. NORWAY MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 223. NORWAY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 226. POLAND MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 227. POLAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. POLAND MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 229. POLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 232. QATAR MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 233. QATAR MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. QATAR MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 235. QATAR MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 238. RUSSIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 239. RUSSIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. RUSSIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 241. RUSSIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 244. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 256. SPAIN MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 257. SPAIN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. SPAIN MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 259. SPAIN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 261. SWEDEN MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 262. SWEDEN MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 263. SWEDEN MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. SWEDEN MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 265. SWEDEN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 268. SWITZERLAND MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. SWITZERLAND MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 273. TURKEY MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 274. TURKEY MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 275. TURKEY MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. TURKEY MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 277. TURKEY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 286. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD MILLION)
  • TABLE 290. MENOPAUSE MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 291. MENOPAUSE MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 292. MENOPAUSE MARKET LICENSE & PRICING
目次
Product Code: MRR-B973EDD5E63E

The Global Menopause Market is forecasted to grow significantly, with a projected USD 17.79 billion in 2023 at a CAGR of 6.83% and expected to reach a staggering USD 28.29 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Menopause Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Menopause Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Treatment, market is studied across Dietary Supplements and OTC Pharma Products. The OTC Pharma Products is further studied across Hormonal products and Non-hormonal products. The Hormonal products is further studied across Combination Estrogen and Other Medicines, Combination Estrogen and Progestin Medicines, Estrogen-Only Medicines, and Progestin-Only Medicines. The OTC Pharma Products is projected to witness significant market share during forecast period.

Based on Product Type, market is studied across Gel, Injection, Oral Dosage, Patch, Pill, Powder, Skin Cream, Skin Spray (Transdermal), Vaginal Cream, and Vaginal Ring. The Skin Spray (Transdermal) is projected to witness significant market share during forecast period.

Based on Indication, market is studied across Dry Eyes, Dry Skin, Hot Flashes, Mood Swings, Mild depression & Irritability, Night Sweats and Cold Flashes., Osteoporosis, Trouble Sleeping, Urinary Urgency, and Vaginal Dryness. The Urinary Urgency is projected to witness significant market share during forecast period.

Based on Distribution Challenge, market is studied across Hospital Pharmacies, Online Stores, and Retail Pharmacies. The Online Stores is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Menopause Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Menopause Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Menopause Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Menopause Market?

4. What is the competitive strategic window for opportunities in the Global Menopause Market?

5. What are the technology trends and regulatory frameworks in the Global Menopause Market?

6. What is the market share of the leading vendors in the Global Menopause Market?

7. What modes and strategic moves are considered suitable for entering the Global Menopause Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Menopause Market, by Treatment, 2022 vs 2030
  • 4.3. Menopause Market, by Product Type, 2022 vs 2030
  • 4.4. Menopause Market, by Indication, 2022 vs 2030
  • 4.5. Menopause Market, by Distribution Challenge, 2022 vs 2030
  • 4.6. Menopause Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of vasomotor and other menopausal symptoms
      • 5.1.1.2. Rising awareness regarding menopause health
      • 5.1.1.3. Increasing number of new drug approvals for the treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects associated with hormonal products and the availability of generic medicines
    • 5.1.3. Opportunities
      • 5.1.3.1. Prevalence of herbal treatment for menopause
      • 5.1.3.2. Increasing research supporting the advantages of dietary supplements
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of advanced healthcare infrastructure in developing nations
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Menopause Market, by Treatment

  • 6.1. Introduction
  • 6.2. Dietary Supplements
  • 6.3. OTC Pharma Products
    • 6.3.1. Hormonal products
      • 6.3.1.1. Combination Estrogen and Other Medicines
      • 6.3.1.2. Combination Estrogen and Progestin Medicines
      • 6.3.1.3. Estrogen-Only Medicines
      • 6.3.1.4. Progestin-Only Medicines
    • 6.3.2. Non-hormonal products

7. Menopause Market, by Product Type

  • 7.1. Introduction
  • 7.2. Gel
  • 7.3. Injection
  • 7.4. Oral Dosage
  • 7.5. Patch
  • 7.6. Pill
  • 7.7. Powder
  • 7.8. Skin Cream
  • 7.9. Skin Spray (Transdermal)
  • 7.10. Vaginal Cream
  • 7.11. Vaginal Ring

8. Menopause Market, by Indication

  • 8.1. Introduction
  • 8.2. Dry Eyes
  • 8.3. Dry Skin
  • 8.4. Hot Flashes
  • 8.5. Mood Swings, Mild depression & Irritability
  • 8.6. Night Sweats and Cold Flashes.
  • 8.7. Osteoporosis
  • 8.8. Trouble Sleeping
  • 8.9. Urinary Urgency
  • 8.10. Vaginal Dryness

9. Menopause Market, by Distribution Challenge

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Online Stores
  • 9.4. Retail Pharmacies

10. Americas Menopause Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Menopause Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Menopause Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing